Showing results 9006 to 9025 of 14621
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2015 | Mutations in KCNT1 cause a spectrum of focal epilepsies | Møller, R.; Heron, S.; Larsen, L.; Lim, C.; Ricos, M.; Bayly, M.; Van Kempen, M.; Klinkenberg, S.; Andrews, I.; Kelley, K.; Ronen, G.; Callen, D.; McMahon, J.; Yendle, S.; Carvill, G.; Mefford, H.; Nabbout, R.; Poduri, A.; Striano, P.; Baglietto, M.; et al. |
| 2013 | Mutations in PRRT2 are not a common cause of infantile epileptic encephalopathies | Heron, S.; Ong, Y.; Yendle, S.; McMahon, J.; Berkovic, S.; Scheffer, I.; Dibbens, L. |
| 1996 | Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence | Tilley, W.D.; Buchanan, G.; Hickey, T.E.; Bentel, J.M. |
| 2018 | Mutations in the epithelial cadherin-p120-catenin complex cause Mendelian non-syndromic cleft lip with or without cleft palate | Cox, L.; Cox, T.; Moreno Uribe, L.; Zhu, Y.; Richter, C.; Nidey, N.; Standley, J.; Deng, M.; Blue, E.; Chong, J.; Yang, Y.; Carstens, R.; Anand, D.; Lachke, S.; Smith, J.; Dorschner, M.; Bedell, B.; Kirk, E.; Hing, A.; Venselaar, H.; et al. |
| 2014 | Mutations in the Human UBR1 Gene and the Associated Phenotypic Spectrum | Sukalo, M.; Fiedler, A.; Guzman, C.; Spranger, S.; Addor, M.; Mcheik, J.; Benavent, M.; Cobben, J.; Gillis, L.; Shealy, A.; Deshpande, C.; Bozorgmehr, B.; Everman, D.; Stattin, E.; Liebelt, J.; Keller, K.; Bertola, D.; van Karnebeek, C.; Bergmann, C.; Liu, Z.; et al. |
| 2017 | Mutations in tropomyosin 4 underlie a rare form of human macrothrombocytopenia | Pleines, I.; Woods, J.; Chappaz, S.; Kew, V.; Foad, N.; Ballester-Beltrán, J.; Aurbach, K.; Lincetto, C.; Lane, R.M.; Schevzov, G.; Alexander, W.S.; Hilton, D.J.; Astle, W.J.; Downes, K.; Nurden, P.; Westbury, S.K.; Mumford, A.D.; Obaji, S.G.; Collins, P.W.; BioResource, N.; et al. |
| 2015 | Mutations of protocadherin 19 in female epilepsy (PCDH19-FE) lead to allopregnanolone deficiency | Tan, C.; Shard, C.; Ranieri, E.; Hynes, K.; Pham, D.; Leach, D.; Buchanan, G.; Corbett, M.; Shoubridge, C.; Kumar, R.; Douglas, E.; Nguyen, L.; Mcmahon, J.; Sadleir, L.; Specchio, N.; Marini, C.; Guerrini, R.; Moller, R.; Depienne, C.; Haan, E.; et al. |
| 2017 | My atrial fibrillation is not your atrial fibrillation | Kirchhof, P.; Sanders, P. |
| 2019 | MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells | Yang, R.M.; Nanayakkara, D.; Kalimutho, M.; Mitra, P.; Khanna, K.K.; Dray, E.; Gonda, T.J. |
| 2012 | Myb-binding protein 1A (MYBBP1A) is essential for early embryonic development, controls cell cycle and mitosis, and acts as a tumor suppressor | Mori, S.; Bernardi, R.; Laurent, A.; Resnati, M.; Crippa, A.; Gabrieli, A.; Keough, R.; Gonda, T.; Blasi, F.; Plow, E. |
| 2012 | Myb-binding protein 1a (Mybbp1a) regulates levels and processing of pre-ribosomal RNA | Hochstatter, J.; Hoelzel, M.; Rohrmoser, M.; Schermelleh, L.; Leonhardt, H.; Keough, R.; Gonda, T.; Imhof, A.; Eick, D.; Laengst, G.; Nemeth, A. |
| 2003 | Myb-binding protein 1a is a nucleocytoplasmic shuttling protein that utilizes CRM1-dependent and independent nuclear export pathways | Keough, R.; Macmillan, E.; Lutwyche, J.; Gardner, J.; Tavner, F.; Jans, D.; Henderson, B.; Gonda, T. |
| 2018 | Mycobacterium tuberculosis Dethiobiotin Synthetase Facilitates Nucleoside Triphosphate Promiscuity through Alternate Binding Modes | Thompson, A.P.; Salaemae, W.; Pederick, J.L.; Abell, A.D.; Booker, G.W.; Bruning, J.B.; Wegener, K.L.; Polyak, S.W. |
| 1997 | Mycophenolate mofetil in renal allograft recipients. | Halloran, P.; Mathew, T.; Tomlanovich, S.; Groth, C.; Hooftman, L.; Barker, C. |
| 2016 | Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort study | Owen, C.; Ngian, G.; Elford, K.; Moore, O.; Stevens, W.; Nikpour, M.; Rabusa, C.; Proudman, S.; Roddy, J.; Zochling, J.; Hill, C.; Sturgess, A.; Tymms, K.; Youssef, P.; Sahhar, J. |
| 2014 | Mycophenolate mofetil versus azathioprine in scleroderma-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study | Owen, C.; Ngian, G.; Elford, K.; Moore, O.; Nikpour, M.; Stevens, W.; Proudman, S.; Roddy, J.; Zochling, J.; Hill, C.; Nash, P.; Sturgess, A.; Sahhar, J.; 2014 ACR/ARHP Annual Meeting (14 Nov 2014 - 19 Nov 2014 : Boston, MA) |
| 2014 | Mycophenolate mofetil versus azathioprine in scleroderma-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study | Owen, C.; Ngian, G.; Moore, O.; Stevens, W.; Proudman, S.; Roddy, J.; Zochling, J.; Nash, P.; Hill, C.; Sturgess, A.; Sahhar, J.; Australian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania) |
| 1984 | Mycoplasma pneumoniae: acute illness, antibiotics, and subsequent pulmonary function | Sabato, A.R.; Martin, A.J.; Marmion, B.P.; Kok, T.W.; Cooper, D.M. |
| 2013 | MyD88 is a critical regulator of hematopoietic cell-mediated neuroprotection seen after stroke | Downes, C.E.; Wong, C.H.Y.; Henley, K.J.; Guio-Aguilar, P.L.; Zhang, M.; Ates, R.; Mansell, A.; Kile, B.T.; Crack, P.J.; Arumugam, T.V. |
| 2017 | Myeloid neoplasms with germline DDX41 mutation | Cheah, J.; Hahn, C.; Hiwase, D.; Scott, H.; Brown, A. |
